Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides.
about
Proteinaceous Molecules Mediating Bifidobacterium-Host InteractionsBifidobacterium longum subspecies infantis: champion colonizer of the infant gutThe impact of the milk glycobiome on the neonate gut microbiotaDiscovering probiotic microorganisms: in vitro, in vivo, genetic and omics approachesCrystal Structures of a Glycoside Hydrolase Family 20 Lacto-N-biosidase from Bifidobacterium bifidum1,3-1,4- -L-Fucosynthase That Specifically Introduces Lewis a/x Antigens into Type-1/2 ChainsA β1-6/β1-3 galactosidase from Bifidobacterium animalis subsp. lactis Bl-04 gives insight into sub-specificities of β-galactoside catabolism within BifidobacteriumConsumption of human milk glycoconjugates by infant-associated bifidobacteria: mechanisms and implications.A holobiont birth narrative: the epigenetic transmission of the human microbiomeBifidobacteria-host interactions--an update on colonisation factors.Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolatesIdentification and accurate quantitation of biological oligosaccharide mixtures.Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycansMolecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal ProbiomeUtilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependentComparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria.The Influence of Early Infant-Feeding Practices on the Intestinal Microbiome and Body Composition in Infants.Genomics of the Genus Bifidobacterium Reveals Species-Specific Adaptation to the Glycan-Rich Gut EnvironmentA molecular basis for bifidobacterial enrichment in the infant gastrointestinal tractBifidobacterial enzymes involved in the metabolism of human milk oligosaccharides.Oligosaccharides Released from Milk Glycoproteins Are Selective Growth Substrates for Infant-Associated Bifidobacteria.Lacto-N-biosidase encoded by a novel gene of Bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expressionA novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596.Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways.Exo- and endoglycosidases revisited.α-N-Acetylglucosaminidase from Bifidobacterium bifidum specifically hydrolyzes α-linked N-acetylglucosamine at nonreducing terminus of O-glycan on gastric mucin.Bifidobacterial α-galactosidase with unique carbohydrate-binding module specifically acts on blood group B antigen.Mucin glycan foraging in the human gut microbiome.Host-derived glycans serve as selected nutrients for the gut microbe: human milk oligosaccharides and bifidobacteria.Genome Structure of the Symbiont Bifidobacterium pseudocatenulatum CECT 7765 and Gene Expression Profiling in Response to Lactulose-Derived Oligosaccharides.Bifidobacterium longum subsp. longum Exo-β-1,3-Galactanase, an enzyme for the degradation of type II arabinogalactan.Comparative Genomics Revealed Genetic Diversity and Species/Strain-Level Differences in Carbohydrate Metabolism of Three Probiotic Bifidobacterial SpeciesDistinct substrate specificities of three glycoside hydrolase family 42 β-galactosidases from Bifidobacterium longum subsp. infantis ATCC 15697.Discovery of α-L-arabinopyranosidases from human gut microbiome expands the diversity within glycoside hydrolase family 42.A unique gene cluster for the utilization of the mucosal and human milk-associated glycans galacto-N-biose and lacto-N-biose in Lactobacillus casei.Bifidobacteria and the infant gut: an example of co-evolution and natural selection.Human milk and mucosal lacto- and galacto-N-biose synthesis by transgalactosylation and their prebiotic potential in Lactobacillus species.Non-digestible carbohydrates in infant formula as substitution for human milk oligosaccharide functions: Effects on microbiota and gut maturation.Milk Glycans and Their Interaction with the Infant-Gut Microbiota.
P2860
Q26740603-1A252948-968B-412D-9520-C7D8CD92A7E7Q26823017-7A802DBC-9205-4ECA-AD57-51A7462ACD5EQ26860976-CB847F7D-1AD3-4012-8324-A3DE51E4E596Q27012682-1D1213E6-B1CD-4660-BF57-2B4B963153E3Q27676765-16B6DB63-B0E2-470D-A4C6-94BC04970AC8Q27678219-3BCD7DAA-462C-4EAF-80A4-3319E512D94BQ27695689-C9EBB589-E91F-4245-84E3-26ED5B2EBDDBQ33852500-EBE173B6-7359-4A55-8E2A-9EE3859691FCQ34063116-45C69788-B3A5-4E54-A113-5B987F95B64DQ34256838-FBF19C60-F32E-4BF7-BB55-C3BFA4FA1D38Q34314729-47D2475B-C20D-4143-A7EF-AAA9046870D0Q34381583-FD6E4260-2FAC-4A83-8A50-B795EC218E3CQ34612202-01052FF3-EAA7-448A-884D-D6CC97962E19Q34629039-176C75D0-D315-4223-91A4-B54BEE596FBFQ34881370-3EDDFB23-A9A6-48C8-95C9-FF3697B43573Q35034645-2573462E-6AFB-42AF-ACFD-58B88C264098Q35763938-39509BAF-AAA0-445F-B1F1-D52602A59CEEQ36391078-437B378E-93AE-4B36-B746-EC99CAC5FA42Q36575131-50B2BEA7-02F3-4A02-BA26-75F7969E6F6BQ36830447-95269212-0A26-4199-88BE-931A66D9C6A1Q36830452-A7A59D0C-0D83-4CDC-8C50-D1366A871022Q37122199-DCED29A3-669A-4621-B380-866C4B6AA4DEQ37132084-E612F188-CB9B-43C0-9E80-6953A6A8605EQ37348745-3AD89FA4-FB2A-47F6-9422-AE3289241BD4Q37483852-49EE0EE1-A443-4174-85E8-753EC81527F6Q38087861-3E0CBB37-1399-4AB3-B18D-E9F7DE0C3E50Q38303147-387FEF05-A401-4071-9535-FBA3BAFDA825Q38320578-285EFAFB-E3CE-4CFA-99B7-6A9D347434B8Q38411042-8E9DF8A3-CC57-4EF1-8BFE-D5CA25C167EFQ38720798-32000A24-9FE1-46BF-9F04-A28EB2B08D87Q40785098-B2B5CC10-976C-4580-94D3-0FD8DD4F061CQ41885347-7BC77442-702B-4B2B-A65F-F2A2C4BE9EE5Q42355304-7C0C6BD0-563E-4C6B-9597-A3EC187AFBD1Q45758260-A1F00678-84DB-4787-891C-686308116E2FQ46276845-BC2765DB-74C5-4EDA-8093-04AD39A06107Q46287893-05BEC270-ECEB-446C-8281-672CAC89A4F5Q46293341-6FFD2914-9F5D-4FA5-8740-DEAAD840461DQ46480719-540E5D4D-5E16-49BD-BC24-6659CB353ABBQ50047831-0A20F6D5-3094-46EE-936B-846E817BDC2EQ52341406-6E412AEF-23AF-4A64-B4F6-457BDAF3B770
P2860
Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Bifidobacterium longum subsp. ...... 2 human milk oligosaccharides.
@en
Bifidobacterium longum subsp. ...... 2 human milk oligosaccharides.
@nl
type
label
Bifidobacterium longum subsp. ...... 2 human milk oligosaccharides.
@en
Bifidobacterium longum subsp. ...... 2 human milk oligosaccharides.
@nl
prefLabel
Bifidobacterium longum subsp. ...... 2 human milk oligosaccharides.
@en
Bifidobacterium longum subsp. ...... 2 human milk oligosaccharides.
@nl
P2093
P2860
P356
P1433
P1476
Bifidobacterium longum subsp. ...... 2 human milk oligosaccharides.
@en
P2093
Erina Yoshida
Haruko Sakurama
Hidehiko Kumagai
Hisashi Ashida
Junko Hirose
Kenji Yamamoto
Masashi Kiyohara
Takane Katayama
P2860
P304
P356
10.1093/GLYCOB/CWR116
P577
2011-09-16T00:00:00Z